Logo image of RIME

ALGORHYTHM HOLDINGS INC (RIME) Stock Fundamental Analysis

NASDAQ:RIME - Nasdaq - US8293225020 - Common Stock - Currency: USD

2.33  -0.1 (-4.12%)

After market: 2.45 +0.12 (+5.15%)

Fundamental Rating

1

Overall RIME gets a fundamental rating of 1 out of 10. We evaluated RIME against 64 industry peers in the Household Durables industry. RIME has a bad profitability rating. Also its financial health evaluation is rather negative. RIME is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RIME has reported negative net income.
RIME had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RIME reported negative net income in multiple years.
In multiple years RIME reported negative operating cash flow during the last 5 years.
RIME Yearly Net Income VS EBIT VS OCF VS FCFRIME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

The Return On Assets of RIME (-57.75%) is worse than 95.31% of its industry peers.
RIME has a worse Return On Equity (-392.34%) than 95.31% of its industry peers.
Industry RankSector Rank
ROA -57.75%
ROE -392.34%
ROIC N/A
ROA(3y)-4.64%
ROA(5y)-5.19%
ROE(3y)-5.06%
ROE(5y)-11.61%
ROIC(3y)N/A
ROIC(5y)N/A
RIME Yearly ROA, ROE, ROICRIME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

RIME has a Gross Margin of 18.40%. This is amonst the worse of the industry: RIME underperforms 81.25% of its industry peers.
In the last couple of years the Gross Margin of RIME has declined.
RIME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.32%
GM growth 5Y-1.88%
RIME Yearly Profit, Operating, Gross MarginsRIME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

RIME does not have a ROIC to compare to the WACC, probably because it is not profitable.
RIME has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RIME has been reduced compared to 5 years ago.
The debt/assets ratio for RIME has been reduced compared to a year ago.
RIME Yearly Shares OutstandingRIME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
RIME Yearly Total Debt VS Total AssetsRIME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -2.82, we must say that RIME is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RIME (-2.82) is worse than 92.19% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that RIME is not too dependend on debt financing.
The Debt to Equity ratio of RIME (0.24) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -2.82
ROIC/WACCN/A
WACC12.8%
RIME Yearly LT Debt VS Equity VS FCFRIME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

RIME has a Current Ratio of 0.87. This is a bad value and indicates that RIME is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of RIME (0.87) is worse than 93.75% of its industry peers.
RIME has a Quick Ratio of 0.87. This is a bad value and indicates that RIME is not financially healthy enough and could expect problems in meeting its short term obligations.
RIME's Quick ratio of 0.43 is on the low side compared to the rest of the industry. RIME is outperformed by 85.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.43
RIME Yearly Current Assets VS Current LiabilitesRIME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for RIME have decreased strongly by -10800.45% in the last year.
RIME shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.05%.
The Revenue has been decreasing by -8.36% on average over the past years.
EPS 1Y (TTM)-10800.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.45%
Revenue 1Y (TTM)-10.05%
Revenue growth 3Y0.69%
Revenue growth 5Y-8.36%
Sales Q2Q%-33.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y594.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.22%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RIME Yearly Revenue VS EstimatesRIME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RIME Yearly EPS VS EstimatesRIME Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

RIME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 0.29, the valuation of RIME can be described as very cheap.
Based on the Price/Forward Earnings ratio, RIME is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
RIME's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.08.
Industry RankSector Rank
PE N/A
Fwd PE 0.29
RIME Price Earnings VS Forward Price EarningsRIME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIME Per share dataRIME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200

4.3 Compensation for Growth

RIME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RIME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALGORHYTHM HOLDINGS INC

NASDAQ:RIME (4/17/2025, 8:00:02 PM)

After market: 2.45 +0.12 (+5.15%)

2.33

-0.1 (-4.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)N/A N/A
Inst Owners0.09%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner Change68.39%
Market Cap5.55M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)19900%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.29
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 1.92
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-238.72
EYN/A
EPS(NY)8.16
Fwd EY350.21%
FCF(TTM)-2.33
FCFYN/A
OCF(TTM)-2.31
OCFYN/A
SpS10.98
BVpS1.21
TBVpS-0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.75%
ROE -392.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.4%
FCFM N/A
ROA(3y)-4.64%
ROA(5y)-5.19%
ROE(3y)-5.06%
ROE(5y)-11.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.32%
GM growth 5Y-1.88%
F-Score2
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.59%
Cap/Sales 0.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.43
Altman-Z -2.82
F-Score2
WACC12.8%
ROIC/WACCN/A
Cap/Depr(3y)73%
Cap/Depr(5y)104.63%
Cap/Sales(3y)0.43%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10800.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.45%
EPS Next Y594.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.05%
Revenue growth 3Y0.69%
Revenue growth 5Y-8.36%
Sales Q2Q%-33.32%
Revenue Next Year1.22%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-62.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.18%
OCF growth 3YN/A
OCF growth 5YN/A